(Yicai) Sept. 25 -- Shares of Hengrui Pharmaceuticals rose after the drugmaker granted a unit of Indian peer Glenmark ...
Circulating tumor cells allow researchers to detect cancer early, provide an accurate prognosis, monitor progression, and ...
Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. If you’re ...
The FDA has granted priority review to the supplemental biologics license application (sBLA) of fam-trastuzumab deruxtecan-nxki (T-DXd; Enhertu) for the first-line treatment of patients with ...
Non-small cell lung cancer has been notoriously difficult to treat because of its aggressive nature and tendency to relapse, even after initial successful treatments. This resistance is often linked ...
Shiseido's new Vital Perfection Uplifting & Firming Advanced Eye Cream claims to target correct sagging, deep wrinkles and ...
Zacks Investment Research on MSN
BDTX vs. Cullinan Therapeutic: Which EGFR Challenger Is the Better Buy?
Black Diamond Therapeutics, Inc. (BDTX) is a clinical-stage oncology company developing therapies that target families of ...
Roche announces positive results from phase III evERA study of giredestrant in combo with everolimus in ER-positive advanced breast cancer: Basel Tuesday, September 23, 2025, 15:0 ...
The 2025 European Society for Medical Oncology (ESMO) Congress will take place in Berlin, Germany, from October 17 to 21. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (“Kelun-Biotech”, HKEX: 6990 ...
Hepatocellular carcinoma (HCC) is the second leading cause of cancer death worldwide, largely due to the limited efficacy of ...
Genentech will be heading to regulators after the Phase III success of its oral selective oestrogen receptor degrader (SERD) ...
The tissue engineered skin substitutes market represents a revolutionary advancement in regenerative medicine, offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback